1. Home
  2. RUSHB vs BLTE Comparison

RUSHB vs BLTE Comparison

Compare RUSHB & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rush Enterprises Inc. Class B

RUSHB

Rush Enterprises Inc. Class B

HOLD

Current Price

$79.82

Market Cap

6.1B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$165.53

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RUSHB
BLTE
Founded
1965
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.0B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
RUSHB
BLTE
Price
$79.82
$165.53
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$198.00
AVG Volume (30 Days)
88.6K
136.8K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
1.04%
N/A
EPS Growth
N/A
N/A
EPS
1.68
N/A
Revenue
$7,434,195,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.44
$492.11
P/E Ratio
$46.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.71
$60.00
52 Week High
$81.52
$200.00

Technical Indicators

Market Signals
Indicator
RUSHB
BLTE
Relative Strength Index (RSI) 60.97 55.58
Support Level $73.26 $146.94
Resistance Level $81.52 $172.02
Average True Range (ATR) 2.23 6.70
MACD -0.03 1.40
Stochastic Oscillator 82.57 46.67

Price Performance

Historical Comparison
RUSHB
BLTE

About RUSHB Rush Enterprises Inc. Class B

Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: